Metraipolis › archive › dc_cd9de406a181
Long-Term Real-World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results — Europe PMC PMID:41108618
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41108618
- DOI
- 10.1002/hon.70142
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T21:06:59.931Z
- SHA-256 of the archived text
97d1d410edbc8bf189818bc6d1b3aa53f48b80eb579e7b2b8d069d46202d80bf- Stable URL of this page
https://metraipolis.com/documento/dc_cd9de406a181
How to cite
Long-Term Real-World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results — Europe PMC PMID:41108618 — Europe PMC (en), https://europepmc.org/article/MED/41108618 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd9de406a181 (Metraipolis archive dc_cd9de406a181, sha256 97d1d410edbc8bf189818bc6d1b3aa53f48b80eb579e7b2b8d069d46202d80bf)
BibTeX
@misc{dccd9de406a181,
title = {Long-Term Real-World Outcomes of Primary CNS Lymphoma Patients Treated With MATRix Regimen Are Similar to IELSG32 Trial Results — Europe PMC PMID:41108618},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41108618},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd9de406a181; sha256 97d1d410edbc8bf189818bc6d1b3aa53f48b80eb579e7b2b8d069d46202d80bf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41108618. Agents can read the archived copy with the MCP tool read_document.